HYDI Hydromer Inc.

Hydromer Inc. Expands its Team to Address the Growing Demand in the Biomaterial Coatings Market for Medical Devices

Hydromer Inc. Expands its Team to Address the Growing Demand in the Biomaterial Coatings Market for Medical Devices

Branchburg, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer, Inc. (OTC Pink: HYDI) announces today that Mr. Matt J. McGlon has joined the Hydromer team in the capacity of National and Key Accounts Sales Manager. Matt is a seasoned medical device Sales and Account Management professional with over fifteen years of experience. He has a proven track record of achieving aggressive sales growth and introducing new products and technologies in highly competitive markets. Matt has a comprehensive understanding of med-tech products and technologies in specialties such as Peripheral Vascular and Endoscopic Surgery, Interventional Radiology, Trauma Surgery, Interventional Cardiology, Orthopedics and Sports Medicine. Over the past 15 years, Matt has held key territory and account management positions at world class companies such as CR Bard (now Beckton Dickenson), Atrium Medical, Biomet Orthopedics, and Smith & Nephew Orthopedics, where he not only managed key territories, but also helped drive complex GPO/IDN negotiations. Matt’s academic background includes two BS degrees in Business Management and Marketing and in Exercise Science from Auburn University.

“With the biomaterial coatings market for medical devices projected to reach over $15 billion by 2021 and the flurry of new material science and substrates that customers need surface coatings for, we are very enthusiastic that Matt is bringing his extensive med-tech expertise to further expand our presence in this arena,” said Peter M. von Dyck, Hydromer’s CEO.



Innovating polymers and coatings since 1981, Hydromer, Inc. is a leading ISO 9001:2015 technology-focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer based products for commercial markets including Medical Device, Pharmaceutical, Biotechnology, Industrial Plastics, Cosmetic and Personal Care. Hydromer also provides highly specialized medical coating services to industry through its FDA registered and ISO 13485:2016 certified Medical Products subsidiary.

For the latest information about Hydromer, Inc. and its products, please visit our web site at 



Nikki Barnes

Marketing Specialist

(908) 722-5000

 
EN
19/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydromer Inc.

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Thi...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end ...

 PRESS RELEASE

Hydromer, Inc. Announces the Restructuring and Formation of World-Clas...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development ·       Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions ·       Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologie...

 PRESS RELEASE

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Fin...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to ch...

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Fir...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-en...

 PRESS RELEASE

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Co...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) Hydromer, Inc. (the “Company”) is pleased to provide the following update to shareholders regarding the Company’s progress toward stability and profitable growth. Much has been done since the spring of 2023 in reducing the Company’s overhead and operating costs, which management believes will lead to improved profitability in the current fiscal year. Additionally, investment in new prod...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch